The aim of this study is to compare 6% hydroxyethyl starch (HES) 130/0.4 in a balanced electrolyte solution (Volulyte®) with modified fluid gelatin (Geloplasma®) as the priming solution for the cardiopulmonary bypass (CPB) circuit. The microvascular reactivity and the effects on tissue (StO2) and cerebral (ScO2) oxygen saturation will be examined using near-infrared spectroscopy (NIRS).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Volulyte 6% to the cardiopulmonary bypass circuit.
During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Geloplasma to the cardiopulmonary bypass circuit.
Ghent University Hospital
Ghent, Belgium
Value of the StO2 recovery slope (recStO2) after postocclusive ischaemia.
Values are measured, using near-infrared spectroscopy.
Time frame: after 3 minutes of postocclusive ischaemia
Change of values of ScO2 during cardiopulmonary bypass (CPB ).
Time frame: Continuously during cardiopulmonary bypass (= maximum 3 hours).
Change of value of StO2 during cardiopulmonary bypass.
Time frame: Continuously during cardiopulmonary bypass(= maximum 3 hours).
Change of blood gas analyses during cardiopulmonary bypass.
Time frame: Continuously during cardiopulmonary bypass(= maximum 3 hours).
Change of haemodynamics during cardiopulmonary bypass.
Time frame: Continuously during cardiopulmonary bypass(= maximum 3 hours).
Urinary output during cardiopulmonary bypass.
Time frame: At the end of cardiopulmonary bypass(= after maximum 3 hours)..
Use of vasoactive medication during cardiopulmonary bypass.
Time frame: During complete cardiopulmonary bypass(= maximum 3 hours).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.